m6A-centered Drug Response Information

General Information of the Drug (ID: M6ADRUG0164)
Name
3-deazidenosine
Synonyms
3-DEAZAADENOSINE, 6736-58-9, 3-deaza-adenosine, Deaza-Ado, Adenosine, 3-deaza-, UNII-037V4520IY, 3dAdo, 037V4520IY, NSC 167897, DTXSID2040941, NSC-167897, 1H-Imidazo(4,5-c)pyridine, 4-amino-1-beta-D-ribofuranosyl-, 1H-IMIDAZO(4,5-C)PYRIDIN-4-AMINE, 1-.BETA.-D-RIBOFURANOSYL, (2R,3R,4S,5R)-2-{4-amino-1H-imidazo[4,5-c]pyridin-1-yl}-5-(hydroxymethyl)oxolane-3,4-diol, 1-beta-D-Ribofuranosyl-1H-Imidazo(4,5-c)pyridin-4-amine, 1-beta-D-ribofuranosyl-1H-imidazo[4,5-c]pyridin-4-amine, (2R,3R,4S,5R)-2-(4-amino-1H-imidazo(4,5-c)pyridin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol, 1-.beta.-D-Ribofuranosyl-1H-Imidazo[4,5-c]pyridin-4-amine, DTXCID0020941, 1H-IMIDAZO(4,5-C)PYRIDIN-4-AMINE, 1-BETA-D-RIBOFURANOSYL, 1H-Imidazo(4,5-c)pyridine, 4-amino-1-beta-D-ribofuranosyl-(8CI), dbzqfunlcalwdy-abhrneansa-n, 3-Deaza Adenosine, (2R,3R,4S,5R)-2-(4-aminoimidazo[4,5-c]pyridin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol, 4-Amino-1-(beta-D-ribofuranosyl)-1H-imidazo(4,5)-pyridine, AD3, 3DZA, (2R,3R,4S,5R)-2-(4-Amino-1H-imidazo[4,5-c]pyridin-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, NSC167897, 9-Deazaado, MFCD00153951, DHCDA, C^3Ado, 1hp0, 3-Deazaadenosine, 3-DeazaA, BIDD:GT0703, CHEMBL202701, GTPL5115, SCHEMBL1738519, BDBM82055, DBZQFUNLCALWDY-PNHWDRBUSA-N, AKOS024260271, CS-W014048, DB04546, HY-W013332, ND04697, NCGC00093846-07, AC-32285, AS-78389, PD019530, CAS_6736-58-9, NS00071576, G12425, Q27073728, 1-(beta-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridin-4-amine, 1H-Imidazo(4,5-c)pyridin-4-amine, 1-beta-D-ribofuranosyl-, {1H-Imidazo[4,5-c]pyridine,} 4-amino-1-.beta.-D-ribofuranosyl-, 4-Amino-1--D-ribofuranosyl-1H-imidazo[4,5-c]pyridine;3-Deaza-D-adenosine, (2R,3R,4S,5R)-2-(4-aminoimidazo[4,5-c]pyridin-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
    Click to Show/Hide
Structure
3D MOL
2D MOL
Formula
C11H14N4O4
InChI
InChI=1S/C11H14N4O4/c12-10-7-5(1-2-13-10)15(4-14-7)11-9(18)8(17)6(3-16)19-11/h1-2,4,6,8-9,11,16-18H,3H2,(H2,12,13)/t6-,8-,9-,11-/m1/s1
InChIKey
DBZQFUNLCALWDY-PNHWDRBUSA-N
PubChem CID
23190
TTD Drug ID
D0I7TN
DrugBank ID
DB04546
References
Ref 1 Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease. Nat Rev Drug Discov. 2021 Apr;20(4):265-286. doi: 10.1038/s41573-020-00108-x. Epub 2021 Jan 19.
Ref 2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017210)
Ref 3 Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation. Bioorg Med Chem. 2010 Jan 15;18(2):822-9. doi: 10.1016/j.bmc.2009.11.050. Epub 2009 Nov 27.